Baricitinib vs Rituximab

## Baricitinib vs Rituximab: Overview

This comparison examines the pharmacological differences between **Baricitinib** and **Rituximab**.

## Mechanism of Action

**Baricitinib**: Selective JAK1 and JAK2 inhibitor blocking cytokine signaling involved in inflammation.

**Rituximab**: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

## Pharmacokinetics

**Half-life**: Baricitinib — 12 hours; Rituximab — 22 days.

## Chemical Properties

**Molecular Formula**: Baricitinib — C16H17N7O2S; Rituximab — N/A.

**Molecular Weight**: Baricitinib — 371.4170 g/mol; Rituximab — N/A.

**Type**: Baricitinib — Small molecule; Rituximab — Antibody.